Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Autoimmune myelopathies.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Some recent advances in multiple sclerosis.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Teriflunomide
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Neuro-Immune Interactions at Barrier Surfaces.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Dimethyl fumarate protection against collagen II degradation.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
A silver lining of neuroinflammation: Beneficial effects on myelination.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai

Pages